Dupilumab improves lung function and reduces severe exacerbations in patients with uncontrolled persistent asthma with and without history of atopy

被引：0
|
作者：
Maspero, J. [1 ]
Gawchik, S. M. [2 ]
Zhang, B. [3 ]
Pirozzi, G. [3 ]
Staudinger, H. [3 ]
Evans, R. R. [4 ]
Graham, N. M. H. [4 ]
Louis-Tisserand, M. [3 ]
Teper, A. [3 ]
机构：
[1] Fdn CIDEA, Buenos Aires, DF, Argentina
[2] Asthma & Allergy Associates, Philadelphia, PA USA
[3] Sanofi, Bridgewater, NJ USA
[4] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
来源：
ALLERGY | 2016年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1166
引用
收藏
页码：530 / 530
页数：1
相关论文
共 50 条
  • [21] Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
    Papi, A.
    Castro, M.
    Busse, W. W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGOLOGIE, 2022, 45 (08) : 605 - 605
  • [22] Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
    Papi, A.
    Castro, M.
    Busse, W. W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Castro, M.
    Rabe, K. F.
    Kraft, M.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [24] Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
    Lommatzsch, M.
    Papi, A.
    Castro, M.
    Busse, W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J.
    Rowe, P.
    Deniz, Y.
    PNEUMOLOGIE, 2023, 77 : S90 - S90
  • [25] Dupilumab Improves Lung Function And Reduces Severe Exacerbations In Uncontrolled Asthmatics With Baseline Eosinophil Levels Above And Below 300 Cells/μl
    Wenzel, S. E.
    Wang, L.
    Pirozzi, G.
    Sutherland, E. R.
    Graham, N.
    Evans, R.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] LONG-TERM DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN TYPE 2 PATIENTS WITH/WITHOUT ALLERGIC
    Sher, L.
    Corren, J.
    Pavord, I.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J.
    Deniz, Y.
    Rowe, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S44 - S45
  • [27] Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma
    Gurnell, M.
    Domingo, C.
    Rabe, K. F.
    Menzies-Gow, A.
    Price, D.
    Brusselle, G.
    Wechsler, M. E.
    Xia, C.
    Pandit-Abid, N.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Siddiqui, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [28] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
  • [29] Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
    Busse, William W.
    Maspero, Jorge F.
    Hanania, Nicola A.
    Fitz-Gerald, J. Mark
    Ford, Linda B.
    Rice, Megan
    Lu, Yufang
    Rowe, Paul
    Staudinger, Heribert
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB97 - AB97
  • [30] Dupilumab Reduces Exacerbations And Improves Lung Function In Children (6-11 Years) With Moderate-To-Severe Asthma And High Eosinophils
    Jackson, Daniel
    Hamelmann, Eckard
    Roberts, Graham
    Bacharier, Leonard
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Jacob-Nara, Juby
    Radwan, Amr
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB194 - AB194
12345